THZ531

Overview

THZ531 is a selective and covalent inhibitor of both CDK12 and CDK13 with IC 50 s of 158 nM and 69 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK

Product Information

• Catalog No.: HY-103618
• CAS No.: 1702809-17-3
• Molecular Formula: C30H32ClN7O2
• Molecular Weight: 558.07
• Purity: 99.23%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 1.43 mg/mL (2.56 mM); Clear solution
• Availability: In-stock

Source

Original product source